J&J India to Pay Compensation of ~$28K per Patient for Faulty Hip Implant

 J&J India to Pay Compensation of ~$28K per Patient for Faulty Hip Implant

J&J India to Pay Compensation of ~$28K per Patient for Faulty Hip Implant

Shots:

  • Indian drug regulator CDSCO, has ordered J&J to pay Rs 20 Lakh (~$28K) as interim compensation to all patients received hip implants, after recommendation from government-appointed committee. Also J&J has to extend its medical management till 2025, along with compensation
  • As per J&J 4,700 patients in India have received these implants however 3,600 patients yet to be track down. J&J has also agreed to pay $2.5B to 8,000 patients in 2013 for faulty implants in the US
  • J&J has globally recalled ASR hip implants since 2010, based on leaking of chromium and cobalt which creates toxicity in human body

Click here to read full press releasearticle | Ref: J&J | Image: J&J

Vartika Singh

Vartika Singh is a content writer who loves to write research articles and reports at PharmaShots. She has in-depth knowledge of the life sciences industry including the Pharma and Biotech sectors. Any articles written by her can be contacted at connect@pharmashots.com.

Related post